"Biomarkers and Depression: What the Clinician Needs to Know" was given by Roy Perlis at The 4th Annual Massachusetts General Hospital Colloquium on Depression in Boston, Massachusetts on June 2nd, 2012.

Biomarkers and Depression: What the Clinician Needs to Know - Perlis

Education

Training

Language Courses

Higher Education

K-12

Educational Technology

Medicine

Science & Medicine

Health & Fitness

Overview: Limitations of Current Treatment of Depression Maurizio Fava, MD

Overview: Limitations of Current Treatment of Depression

Assessing and Managing Metabolic Risk in Bipolar Disorder and Schizophrenia Dost Ongur, MD, PhD

Assessing and Managing Metabolic Risk in Bipolar Disorder and Schizophrenia

Long-Acting Injectable (LAI) Antipsychotics in Bipolar Disorder and Schizophrenia Oliver Freudenreich, MD, FAPM

Long-Acting Injectable (LAI) Antipsychotics in Bipolar Disorder and Schizophrenia

Assessment and Treatment of Affective Symptoms in Schizophrenia Oliver Freudenreich, MD, FAPM

Assessment and Treatment of Affective Symptoms in Schizophrenia

Optimal Treatment of Psychosis in Bipolar Disorder Sharmin Ghaznavi, MD, PhD

Biomarkers and Depression: What the Clinician Needs to Know - Perlis

Download our free app to listen on your phone